Jeffrey M. Leiden
2021 - Vertex Pharmaceuticals
In 2021, Jeffrey M. Leiden earned a total compensation of $8.2M as Executive Chairman at Vertex Pharmaceuticals, a 50% decrease compared to previous year.
Compensation breakdown
| Salary | $242,308 |
|---|---|
| Stock Awards | $7,875,259 |
| Other | $39,672 |
| Total | $8,157,239 |
Leiden received $7.9M in stock awards, accounting for 97% of the total pay in 2021.
Leiden also received $242.3K in salary and $39.7K in other compensation.
Rankings
In 2021, Jeffrey M. Leiden's compensation ranked 1,415th out of 12,415 executives tracked by ExecPay. In other words, Leiden earned more than 88.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,415 out of 12,415 | 89th |
Division Manufacturing | 509 out of 5,508 | 91st |
Major group Chemicals And Allied Products | 187 out of 2,378 | 92nd |
Industry group Drugs | 156 out of 2,099 | 93rd |
Industry Pharmaceutical Preparations | 105 out of 1,549 | 93rd |
Source: SEC filing on April 7, 2022.
Leiden's colleagues
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2021.